News for CytoDyn Inc. Stock (CYDY)

CYDY Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds CytoDyn, Inc. Investors With Losses Exceeding $100K of Class Action and Encourages Shareholders to Contact the Firm

Business Wire • 04/13/21

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages CytoDyn Inc. Investors With Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action - CYDY

Newsfile Corp • 04/13/21

Shareholder Alert: Robbins LLP Announces that CytoDyn Inc. (CYDY) is Being Sued for Misleading Shareholders

Business Wire • 04/12/21

CYDY EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces that a Securities Fraud Class Action Lawsuit was filed on Behalf of Investors of CytoDyn Inc.

PRNewsWire • 04/10/21

Important Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds CytoDyn Inc. Investors of Securities Fraud Class Action Lawsuit

Newsfile Corp • 04/09/21

CYTODYN, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP notifies investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York

PRNewsWire • 04/09/21

CytoDyn's COVID-19 Long-Hauler's Trial Closed as Enrollment Exceeds Goals

GlobeNewsWire • 04/08/21

Why Auris Medical, CytoDyn and Prometheus Shares Are Moving Today

Benzinga • 04/08/21

CytoDyn Providing Leronlimab to a Philippine Hospital for 28 More COVID-19 Patients under Compassionate Special Permit (CSP)

GlobeNewsWire • 04/07/21

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CytoDyn, Inc. (CYDY)

PRNewsWire • 04/07/21

Scott+Scott Attorneys at Law LLP Alerts Investors with Losses Over $250,000 to Securities Class Action Against CytoDyn, Inc. (CYDY)

Business Wire • 04/07/21

CytoDyn inks exclusive supply and distribution agreement for leronlimab in Brazil with Biomm SA

Proactive Investors • 04/07/21

CytoDyn Signs Exclusive Supply and Distribution Agreement with Biomm S.A. in Brazil for COVID-19 and All Other Leronlimab Indications

GlobeNewsWire • 04/07/21

Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Lawsuit Filed Against CytoDyn Inc.

Newsfile Corp • 04/06/21

CytoDyn Reschedules Webcast from April 6 to April 7

GlobeNewsWire • 04/05/21

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

PRNewsWire • 04/05/21

CytoDyn Inc. Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against CytoDyn Inc.

PRNewsWire • 04/05/21

CytoDyn executes $28.5M convertible note financing with institutional investor to speed up leronlimab manufacturing

Proactive Investors • 04/05/21

CytoDyn Completes $28.5 Million Convertible Note Financing with Conversion Rate at $10.00 Per Share Without Warrants to Accelerate Manufacturing of Leronlimab Inventory

GlobeNewsWire • 04/05/21

First Compassionate Special Permit (CSP) Patient in Philippines Improved Significantly 35 hours After First Injection of Leronlimab and Released 3 Days Later

GlobeNewsWire • 04/05/21

Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against CytoDyn Inc. - CYDY

Newsfile Corp • 04/03/21

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

Business Wire • 04/02/21

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of CytoDyn, Inc. (CYDY) Investors

PRNewsWire • 04/02/21

CytoDyn (CYDY) Files New Protocol With FDA for COVID-19 Study

Zacks Investment Research • 04/01/21

Shareholder Alert: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed Against CytoDyn Inc.

Newsfile Corp • 04/01/21